Comprehensive Study Notes: Infectious Diseases Affecting the Nervous System (Key Points and Details)

Nervous System and Its Defenses

  • Nervous system components
    • CNS: brain and spinal cord
    • PNS: nerves extending from the CNS to sense organs and the body’s periphery
  • Three main functions
    • Sensory: sensory receptors at ends of peripheral nerves generate nerve impulses transmitted to the CNS
    • Integrative: sensation translated into thought
    • Motor: CNS signals drive muscles and glands
  • Brain and spinal cord anatomy
    • Brain protected by the skull; spinal cord within the vertebral column
    • Soft tissue encased within three meninges: Dura mater (outermost), Arachnoid mater, Pia mater
    • Subarachnoid space between the arachnoid and pia is filled with CSF
  • Cerebrospinal fluid (CSF) and the PNS
    • CSF provides nutrition to the CNS and acts as a liquid cushion for brain and spinal cord
    • Microorganisms can be found in CSF during meningitis
    • PNS: nerves and ganglia
    • Ganglion: swelling where neuron cell bodies aggregate
    • Nerves: bundles of axons transmitting nerve signals
    • Synapse: communication point between adjacent neurons; neurotransmitters released from one cell act on the next

CNS Defenses of the Nervous System

  • Structural defenses
    • Bony casings protect brain and spinal cord
    • CSF cushions CNS
    • Blood–brain barrier (BBB): vascular interface between brain vessels and brain tissue; tight walls limit molecule passage; restricts most microorganisms and many antibiotics
  • Immunological privilege of the CNS
    • CNS is immunologically privileged: limited/modified immune responses to protect vital CNS function
  • Microglia and brain macrophages
    • Phagocytic cells in CNS; reduced activity compared to phagocytes elsewhere in the body

Concept Check 1 (review question excerpted)

  • Which defense prevents certain molecules from entering brain and spinal cord tissue? Answer: ext{Blood–brain barrier}

Normal Biota of the Nervous System

  • Conventional view: no normal biota in CNS or PNS
    • Finding microorganisms in these tissues is typically a deviation from health
    • Herpesviruses can live in a dormant state in the nervous system but are not considered normal microbiota
  • Gut microbiome influences the nervous system (development of brain, BBB, peripheral nerves) during gut development
  • Defenses vs. normal biota
    • Normal biota: none in Nervous System
    • Defenses: bony structures, BBB, microglia/macrophages

Highlight Diseases: Meningitis

  • Inflammation of the meninges; many microorganisms can cause meningitis; symptoms are similar across pathogens
  • Bacterial meningitis: more serious forms
  • Neonatal meningitis etiology differs from children/adults
  • Diagnosis and treatment
    • Lumbar puncture (spinal tap) with CSF Gram stain and/or culture
    • Start broad-spectrum antibiotics immediately
      -Signs and symptoms
    • Severe headache; painful/stiff neck; fever; nausea/vomiting; photophobia; skin rashes in certain types
    • Increased CSF white blood cell count

Neisseria meningitidis (Meningococcus)

  • Gram-negative diplococci; major cause of epidemic meningitis; accounts for 15 ext{-}20 ext{ ext%} of meningitis cases
  • Young children are often affected before vaccine programs; 11 years often the vaccination start age
  • Capsular serotypes: 12 different capsular strains; serotypes B, C, Y responsible for most infections
  • Pathogenesis and virulence
    • Entry via upper respiratory tract; bacteremia; meninges invasion
    • Endotoxin release stimulates WBCs; cytokines cause vascular damage → hemorrhage, petechiae
    • Rare fulminant meningococcemia with high mortality
    • IgA protease and capsule help immune evasion
  • Signs and symptoms
    • Abrupt onset: fever > 40^ ext{C} (≈104^ ext{o}F), sore throat, chills, delirium, widespread bleeding under skin, shock, coma, DIC, adrenal damage, possible death within hours
  • Transmission and epidemiology
    • Not long-surviving in environment; spread via close contact, secretions, droplets
    • Reservoir: humans in nasopharynx; carriers in close contact settings (families, dorms, military housing)
  • Culture, diagnosis, and prevention/treatment
    • CSF/blood/nasopharyngeal samples; Gram stain; oxidase test; rapid tests for capsular polysaccharide
    • Cultures on Modified Thayer–Martin or chocolate agar in high CO2; presumptive genus ID by Gram/oxidase
    • Prevention: rapid treatment is critical; close contacts receive rifampin or tetracycline prophylaxis
    • Treatment: start antibiotics promptly; high-dose penicillin G IV; treat shock/clotting as needed

Streptococcus pneumoniae (Meningitis)

  • Causative agent: Gram-positive, end-to-end diplococci (pneumococcus); leading cause of community-acquired meningitis
  • Association: often linked with pneumonias; 25% of pneumococcal meningitis patients also have pneumococcal pneumonia
  • Susceptibility: more likely in those with underlying conditions
  • Pathogenesis and virulence
    • Polysaccharide capsule inhibits phagocytosis
    • Alpha-hemolysin and hydrogen peroxide damage CNS; can induce brain cell apoptosis
    • Bacteremia and meningitis following respiratory mucosa invasion
  • Prevention and treatment
    • Penicillin resistance common; initial therapy often vancomycin + ceftriaxone
    • If isolate penicillin-sensitive, switch to simpler therapy
    • Vaccines: Prevnar (13-valent) part of childhood immunizations; Pneumovax 23 (23-valent polysaccharide vaccine) for adults

Haemophilus influenzae (Meningitis)

  • Historically a major cause of meningitis; now largely reduced in the U.S. due to vaccination (nonserotype B strains remain a concern globally)
  • Still an important cause of meningitis in children under 5 in parts of the world

Listeria monocytogenes (Meningitis)

  • Causative agent: Gram-positive bacterium; variable morphology; 1–4 flagella
  • Pathogenesis/virulence: not fastidious; resists cold, heat, salt, pH extremes; intracellular growth; cell-to-cell spread
  • Signs and symptoms
    • Healthy adults: often mild or subclinical (fever, diarrhea, sore throat)
    • Elderly, immunocompromised, fetuses, neonates: brain and meninges involvement with septicemia; mortality around 30 ext{–} ext{percent}
  • Transmission and epidemiology
    • Reservoirs in soil/water; foodborne transmission via contaminated dairy, poultry, meat
    • Found in ground beef, chicken/turkey carcasses, luncheon meats, cold cuts, cheeses
  • Culture/diagnosis
    • Cold enrichment (4°C) used for isolation; can take up to 4 weeks
    • Rapid tests: ELISA, immunofluorescence, gene probes for dairy products/cultures
  • Prevention and treatment
    • Antibiotics: ampicillin or penicillin G, then TMP-SMX if needed
    • Prevention: pasteurization, proper washing/cooking; pregnant women advised to avoid soft, unpasteurized cheeses

Cryptococcus neoformans (Meningitis)

  • Signs and symptoms: chronic meningitis with gradual onset; faster in AIDS; may present as meningoencephalitis; headache most common; nausea/neck stiffness also common
  • Causative agent: fungus; spherical/ovoid with a large capsule
  • Transmission/epidemiology: primary ecological niche in birds, especially urban pigeons; high-nitrogen bird droppings; inhaled as dust; healthy individuals usually resistant; AIDS patients at highest risk

Coccidioides species (Meningitis)

  • Causative agent: fungus causing “Valley Fever”; at 25°C forms moist, white-to-brown colonies with branching septate hyphae; arthroconidia (arthrospores) produced; on media at 37–40°C germinates into a spherule
  • Pathogenesis/virulence
    • True systemic fungal infection of high virulence; begins as pulmonary infection; meningitis is the most serious manifestation
    • Inhaled arthrospores → spherules in lungs; some patients progress to disseminated disease (meningitis, osteomyelitis, skin granulomas)
  • Transmission and epidemiology
    • Highest incidence in southwestern U.S. (~100{,}000 cases/year); also in Mexico and parts of Central/South America
    • Outbreaks linked to farming, archeological digs, construction, mining; climate change may widen distribution

Meningitis: Viruses (Aseptic Meningitis)

  • Causes: viruses (no bacteria/fungi/protozoa detected in CSF)
  • Proportion: viruses cause about 4/5 of meningitis cases; majority are viral in children; HSV-2 commonly involved in initial genital infection
  • Typical course: generally milder than bacterial/fungal meningitis; resolves in ~2 weeks; mortality < 1 ext{ ext%}
  • Diagnosis and treatment: ruled out bacteria/fungi/protozoa in CSF; viral culture or antigen tests; usually no treatment needed

Neonatal Meningitis

  • Often transmitted from mother in utero or during birth
  • Increasing incidence with more premature babies; immature immune systems elevate risk
  • Most common causes: Strep. agalactiae (Group B Streptococcus), Escherichia coli (K1), Listeria monocytogenes, Cronobacter sakazakii

Neonatal Meningitis: Streptococcus agalactiae (Group B Strep)

  • Causative agent: colonizes 10–30% of female genital tracts
  • Prevention and treatment
    • Ampicillin or penicillin G
    • High-risk women screened at 35–37 weeks; IV antibiotics at onset of labor; penicillin preferred

Neonatal Meningitis: Escherichia coli (K1 strain)

  • Causative agent: K1 strain common cause
  • Transmission: via birth canal; higher mortality (~20 ext{–}30 ext{ ext%}) even with aggressive therapy
  • Prevention/treatment: IV ceftazidime or cefepime ± gentamicin

Neonatal Meningitis: Cronobacter sakazakii

  • Causative agent: formerly Enterobacter sakazakii
  • Transmission: outbreaks linked to contaminated powdered infant formula
  • Mortality: up to ~40 ext{ ext%}; prevention via ready-to-feed or concentrated liquid formulas; strict hygiene and cleaning of feeding equipment

Zika Virus Disease

  • Microcephaly in babies born to infected mothers; congenital Zika syndrome includes small head, vision problems, seizures, irritability, brainstem dysfunction
  • Causative agent: Zika virus (Flaviviridae; related to dengue, West Nile, yellow fever)
  • Adult symptoms: often mild or asymptomatic; rash, conjunctivitis, muscle/joint pain possible

Poliomyelitis (Polio)

  • Acute enteroviral infection of the spinal cord; can cause neuromuscular paralysis
  • Global eradication efforts persist; large reduction but not fully eradicated
  • Signs and symptoms
    • Initial: mild fever, headache, nausea, sore throat, myalgia
    • If viremia persists: virus reaches CNS → motor neuron invasion; may cause paralysis of legs, abdomen, back, intercostals, diaphragm, etc.; bulbar involvement affects brainstem and respiratory centers
  • Causative agent: poliovirus (family Picornaviridae, genus Enterovirus); nonenveloped, single-stranded RNA genome; acid/immune-resistant capsid
  • Transmission and epidemiology
    • Spread via food, water, hands, fecal-contaminated objects; heavily impacted by vaccination programs; Western Hemisphere elimination achieved; remaining endemic in Afghanistan and Pakistan (as of provided content)
  • Treatment and prevention
    • Treatment mainly supportive; pain relief, respiratory support if needed; physical therapy later
    • Vaccines: IPV (inactivated) by Salk; OPV (oral, Sabin) with attenuated virus; OPV risk of reversion to virulent strains; IPV use common in many areas; immunization schedule and booster considerations

Meningoencephalitis

  • Caused by two amoebas: Naegleria fowleri and Acanthamoeba
  • Naegleria fowleri
    • Emergence: swimming in warm natural freshwater
    • Pathogenesis: amoeba forced into nasal passages; migrates to brain causing primary amoebic meningoencephalitis (PAM) with massive brain/spinal tissue destruction; rapid progression; death typically within a week
    • Transmission/epidemiology: widespread in fresh water; rare but devastating; children often carriers
    • Prevention/treatment: early amphotericin B, sulfadiazine, or tetracycline-based regimens may offer some benefit; pool and bath water chlorination is important
  • Acanthamoeba
    • Similar but longer course; granulomatous amoebic meningoencephalitis (GAM)
    • Transmission: through broken skin, conjunctiva, lungs, urogenital epithelia; risk higher for contact lens wearers, eye trauma, AIDS

Acute Encephalitis

  • Encephalitis: brain inflammation; can be acute or subacute; serious condition
  • Common causes
    • Arboviruses (West Nile, etc.) borne by insects; JC virus and herpesviruses also implicated
    • Bacterial causes exist but meningitis symptoms predominate
  • Signs and symptoms
    • Behavior changes, confusion, decreased consciousness, seizures
  • Prevention and treatment
    • Empiric acyclovir for suspected herpesvirus encephalitis; treatment for other etiologies supportive and not harmful

Arthropod-Borne Viruses (Arboviruses)

  • Transmission and epidemiology
    • Vectors (mosquitoes/arthropods) are most active in late spring to early fall; warm seasons drive peak incidences
    • Humans are often dead-end hosts (e.g., equine encephalitis) or maintenance reservoirs (e.g., yellow fever)
  • Clinical impact
    • Millions infected annually; thousands dead
    • Common outcome: acute fever, often with rash; encephalitis signs vary by virus
  • Diagnosis and management
    • Travel/vectors history; serology and nucleic acid tests available for some viruses
    • No universal antiviral treatment; focus on supportive care and vector control (mosquito abatement)
  • Arboviral encephalitis pathogenesis
    • Bite → virus replication in lymphatic tissue → prolonged viremia and brain infection → inflammation, brain/spinal cord/meningeal damage

Herpes Simplex Virus Encephalitis

  • HSV-1 and HSV-2 can cause encephalitis; neonatal cases from HSV-positive mothers have poor prognosis
  • HSV-1 encephalitis: reactivation from trigeminal ganglion; adults and older children are affected
  • Varicella-zoster virus can also reactivate to cause encephalitis

JC Virus and Subacute Encephalitis

  • JC virus (polyomavirus) commonly infects humans asymptomatically
  • Progressive multifocal leukoencephalopathy (PML): demyelination due to JC virus in immune-compromised individuals (notably AIDS); generally fatal; zidovudine has saved some lives
  • Subacute encephalitis: slower onset; causes include Toxoplasma gondii, persistent measles virus, prions (spongiform encephalopathies), and other infections with distant primary sites

Toxoplasma gondii

  • Infection in fetus or immunocompromised hosts is severe and often fatal
  • In otherwise healthy individuals, infection may be asymptomatic or mild; congenital infection risk with maternal transmission
  • Congenital infection risks if infection in first or second trimester: stillbirth, hepatosplenomegaly, liver failure, hydrocephalus, seizures, retinopathy
  • Pathogenesis and life cycle
    • Obligate intracellular parasite; cat lifecycle with oocysts shed in feces; oocysts persist in moist soil
    • Tissue cysts (pseudocysts) form in intermediate hosts; parasite manipulates rat brain to avoid cat urine (favors life cycle continuation)
  • Transmission and epidemiology
    • Humans commonly exposed (~90% prior exposure)
    • Transmission sources: undercooked meat, cat feces handling, inhalation of contaminated dust, vertical transmission
  • Prevention
    • Adequate cooking/freezing below -20°C; hand hygiene after handling cats or cat feces

Measles-Related Subacute Sclerosing Panencephalitis (SSPE)

  • Occurs years after initial measles infection; slow, progressive, fatal; persistence of measles virus in neural tissue is implicated
  • Factors leading to persistence not fully understood

Prions and Transmissible Spongiform Encephalopathies (TSEs)

  • Prions: proteinaceous infectious particles with no nucleic acids; cause neurodegenerative diseases with long incubation and rapid progression
  • Human TSEs: Creutzfeldt–Jakob disease (CJD), Gerstmann–Sträussler–Scheinker syndrome, fatal familial insomnia
  • Animal TSEs: scrapie, bovine spongiform encephalopathy (BSE, “mad cow” disease)
  • CJD: clinical features include altered behavior, dementia, memory loss, sensory impairment, delirium, and fast progression to death; prion protein PrP misfolding drives disease
  • Transmission and epidemiology
    • vCJD linked to BSE with meat product exposure (Great Britain case cluster); median ages differ by form (vCJD ≈ 28 years vs other CJD ≈ 68 years)
    • Prions are hardy and resistant to standard disinfection; healthcare settings require updated CDC guidelines for handling suspected cases

Rabies

  • Slow, progressive zoonotic encephalitis; nearly worldwide distribution except where animal control is strict
  • Incubation: typically 2 weeks to years; shorter with facial/neck wound exposure
  • Prodromal phase: fever, nausea, vomiting, headache, fatigue
  • Historically, humans were thought not to survive; recent advances saw rare recoveries with aggressive care
  • Pathogenesis and virulence
    • Virus enters via bite or contact with contaminated saliva; travels via neurons to CNS; eventually reaches salivary glands and is shed in saliva
  • Transmission and epidemiology
    • Primary reservoirs: wild mammals (canines, skunks, raccoons, badgers, cats, bats)
    • Worldwide cases primarily from bats in modern times
    • Diagnostic approaches: RT-PCR on saliva; serology for serum/spinal fluid antibodies; skin biopsy
  • Prevention and treatment
    • After exposure: passive immunization with human rabies immune globulin (HRIG) plus active vaccination series; immediate wound care
    • High-risk groups may receive accelerated vaccination; DNA vaccine development ongoing

Tetanus and Botulism

Tetanus

  • Cause: Clostridium tetani; gram-positive, endospore-forming bacillus found in soil and animal GI tracts
  • Endospores are dormant unless in anaerobic wound environments
  • Tetanospasmin toxin
    • Neurotoxin released at wound site; travels to motor neurons and spinal cord; inhibits neurotransmitter release leading to uncontrolled muscle contraction
    • Early signs: trismus (jaw clenching), risus sardonicus (sardonic grin); progresses to arching back and spasm of arched posture; respiratory failure can cause death
  • Transmission: puncture wounds, burns, umbilical stumps, frostbite, crushed tissue
  • Prevention and treatment
    • TIG (tetanus immune globulin) for immediate passive protection plus penicillin G
    • Vaccination: series starting at 2 months with boosters; protection lasts about 10 ext{ years}; pregnant women should be vaccinated
    • Toxoid with TIG recommended for those with uncertain or outdated immunization status

Botulism

  • Causative agent: Clostridium botulinum; endospore-forming anaerobe; botulinum neurotoxin causes disease
  • Forms of botulism
    • Foodborne (intoxication): ingestion of toxin; common in the U.S.
    • Wound botulism: endospores contaminate wounds, toxin produced in situ
    • Infant botulism: ingestion of endospores (often honey) leading to toxin production in gut; immature gut flora
  • Signs and symptoms
    • Toxin blocks acetylcholine release at neuromuscular junctions → flaccid paralysis
    • Onset typically 12–72 hours after exposure; vision problems, dysphagia, dizziness early; progressive descending paralysis and respiratory failure can occur
  • Causative agent details
    • Clostridium botulinum is worldwide; types A, B, E (human disease) and others vary by geography; extremely potent neurotoxin
  • Diagnosis and prevention/treatment
    • Diagnosis often via detection of toxin in food or toxin/organism in patient samples
    • Antitoxin treatment available through CDC; supportive care including respiratory and cardiac support
    • Hospitalization required; recovery can take weeks; mortality around 5 ext{ ext%} with modern care

Quick Concept Review and Connections

  • CNS vs PNS defenses rely on anatomy (BBB, bony casing) and immune features (microglia, privileged status)
  • Meningitis can be bacterial, viral, fungal, or parasitic; treatment urgency hinges on pathogen type due to rapid deterioration in bacterial meningitis
  • Vaccination dramatically changes epidemiology for several bacterial meningitis agents (e.g., S. pneumoniae, H. influenzae, N. meningitidis) and polio eradication efforts
  • Arboviruses illustrate vector-borne neuroinvasive disease with emphasis on prevention (vector control) rather than curative antivirals
  • Subacute and chronic CNS infections (toxoplasma, prions, SSPE) highlight long incubation periods and often severe outcomes despite initially mild symptoms
  • Foodborne/animalborne diseases (Listeria, Cronobacter, Coccidioides, Toxoplasma) underscore the importance of food safety, pregnancy considerations, and geographical risk
  • Zoonoses such as rabies and tetanus emphasize post-exposure prophylaxis and vaccination strategies
  • Practical implications include rapid diagnostic workflows (CSF analysis, Gram stains, culture on specialized media), prompt empiric therapy in suspected meningitis, and prevention strategies (vaccines, vector control, safe food handling, and wound care)

ext{Key numerical references: }

  • Neisseria meningitidis serotypes: 12 serotypes; major serotypes B, C, Y
  • Meningitis share among pathogens: bacterial forms often more severe; viral causes common in pediatrics
  • Mortality and risk figures: N. meningitidis high-risk outcomes; meningococcal disease mortality around 15 ext{ ext%} in treated cases; Listeria meningitis ~30 ext{ ext%} mortality in certain groups
  • Vaccination and protection durations: pneumococcal vaccines include 13 ext{-valent} Prevnar and 23 ext{-valent} Pneumovax; tetanus protection about 10 ext{ years}; polio vaccines IPV and OPV
  • Temperature captions: fever thresholds such as > 40^ ext{C} (104°F) in meningococcal presentation
  • Timeframes: rabies incubation highly variable from weeks to years; botulism onset 12–72 hours after exposure